Vincerx Pharma Statistics
Share Statistics
Vincerx Pharma has 5.23M
shares outstanding. The number of shares has increased by 51.66%
in one year.
| Shares Outstanding | 5.23M |
| Shares Change (YoY) | 51.66% |
| Shares Change (QoQ) | 22.83% |
| Owned by Institutions (%) | 0.03% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 133.31K, so 5.95% of the outstanding
shares have been sold short.
| Short Interest | 133.31K |
| Short % of Shares Out | 5.95% |
| Short % of Float | 6.57% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.33 and the forward
PE ratio is null.
Vincerx Pharma's PEG ratio is
0.
| PE Ratio | -0.33 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 3.67 |
| P/FCF Ratio | -0.38 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Vincerx Pharma.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.21,
with a Debt / Equity ratio of 0.
| Current Ratio | 1.21 |
| Quick Ratio | 1.21 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-2,506,166.67 |
| Employee Count | 12 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by null% in the
last 52 weeks. The beta is 1.39, so Vincerx Pharma's
price volatility has been higher than the market average.
| Beta | 1.39 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.59 |
| 200-Day Moving Average | 6.31 |
| Relative Strength Index (RSI) | 18.03 |
| Average Volume (20 Days) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -31.46M |
| Net Income | -30.07M |
| EBITDA | -31.46M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -15.85 |
Full Income StatementBalance Sheet
The company has 4.99M in cash and 0 in
debt, giving a net cash position of 4.99M.
| Cash & Cash Equivalents | 4.99M |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | -189.19M |
| Total Assets | 8.01M |
| Working Capital | 1.13M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -26.13M
and capital expenditures 0, giving a free cash flow of -26.13M.
| Operating Cash Flow | -26.13M |
| Capital Expenditures | n/a |
| Free Cash Flow | -26.13M |
| FCF Per Share | -13.77 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
